Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Techniques for Quantitative Cancer Imaging: Current Status

Sunday, Nov. 25, 2:00-3:30 p.m. | S404AB
Speakers will discuss quantitative imaging applications of CT, MRI and PET. Specific topics include development of a new response assessment criteria based on tumor volume and density changes on CT, use of dynamic-contrast enhanced MRI and diffusion-weighted imaging and techniques for reducing variability in quantitative PET/CT imaging.

Post-op rad therapy slows progression of prostate cancer in 60% of men

Radiotherapy immediately following removal of the prostate has long-term benefits for preventing the biochemical progression of prostate cancer, with more than 60 percent of men remaining disease-free after a decade, according to a study published online first in The Lancet.

U.K. researchers aim to predict cancer risk, streamline diagnosis

U.K. researchers have launched the CANcer DIagnosis Decision (CANDID) rules study, with the goal of predicting who is at higher risk for cancer. Ultimately, such information may help curb unnecessary diagnostic procedures.

Fleischner Society takes aim at incidental subsolid pulmonary nodules

In an effort to plug gaps in its original recommendations for the management of pulmonary nodules, the Fleischner Society issued six recommendations for follow-up of subsolid nodules detected by CT imaging.

Nearly 170 million years of healthy life lost due to cancer in 2008

Cancer contributed to 7.6 million deaths worldwide in 2008, and was linked with nearly 170 million years of healthy life lost, according to a study published online Oct. 16 in The Lancet.

Accuray CEO resigns after a decade

Accuray's President, CEO and Director of the Board, Euan S. Thomson, has resigned. Accuray's Board has appointed Joshua H. Levine as his successor as president, CEO and director of the board, effective immediately. Thomson is anticipated to continue in a consulting role with the company.

Active surveillance for prostate cancer: A tough sell

Physicians view active surveillance for prostate cancer as effective for managing low-risk prostate cancer, but few recommend the strategy, according to results of a national survey presented Oct. 12 at the North Central American Urological Association Meeting.

Low-dose, but high risk: Malignant lung nodule growth missed on unenhanced CT follow-up

For relatively small lung nodules, low-dose unenhanced CT significantly underestimates volume, increasing the risk that malignant growth rates will be missed at follow-up, according to a study published in the October issue of the American Journal of Roentgenology.

Displaying 785 - 792 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.